Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-25 @ 7:09 PM
Study NCT ID:
NCT00294632
Status:
COMPLETED
Last Update Posted:
2020-02-24
First Post:
2006-02-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
2016-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-20
First Submit QC Date:
None
Study First Post Date:
2006-02-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-06
Results First Submit QC Date:
None
Results First Post Date:
2020-02-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-17
Last Update Post Date:
2020-02-24
Last Update Post Date Type:
ACTUAL